サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1381140

血漿療法市場：タイプ別、用途別-2023-2030年の世界予測

Plasma Therapy Market by Type (Leucocyte-rich PRP, Leukocyte-rich Fibrin (L-PRF), Pure Platelet-rich Fibrin (PRF)), Application (Dental, Dermatology, Nerve Injury) - Global Forecast 2023-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 190 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
血漿療法市場：タイプ別、用途別-2023-2030年の世界予測
出版日: 2023年10月16日
発行: 360iResearch
ページ情報: 英文 190 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

血漿療法市場は、2022年の3億2,891万米ドルから2030年には7億8,195万米ドルに達すると予測され、予測期間中のCAGRは11.43%です。

血漿療法の世界市場

主な市場の統計
市場金額：基準年[2022] 3億2,891万米ドル
推定市場金額[2023] 3億5,973万米ドル
予測市場金額[2030]USD 781.95 million 7億8,195万米ドル
CAGR（%） 11.43%
血漿療法 Market-IMG1

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは血漿療法市場の評価に不可欠なツールです。事業戦略と製品満足度に関連する主要指標を分析し、ベンダーを包括的に評価します。これにより、ユーザーは特定のニーズに合わせた情報に基づいた意思決定を行うことができます。高度な分析により、ベンダーは4つの象限に分類され、それぞれ成功のレベルが異なります：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。この洞察に満ちたフレームワークにより、意思決定者は自信を持って市場をナビゲートすることができます。

市場シェア分析

市場シェア分析では、ベンダーの市場情勢に関する貴重な洞察を提供します。全体収益、顧客ベース、その他の主要指標への影響を評価することで、企業の業績と直面する競合環境を包括的に理解することができます。この分析では、調査期間中の市場シェア獲得、断片化、優位性、業界再編などの競合レベルも明らかにします。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1.市場の浸透度：主要企業の市場力学と製品に関する包括的な情報を提供します。

2.市場の開拓度：新興市場と成熟市場セグメントへの浸透度を詳細に分析し、有利なビジネスチャンスを浮き彫りにします。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細情報。

4.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価。

5.製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関するインテリジェントな洞察。

本レポートは、以下のような主要な質問に対応しています：

1.血漿療法市場の市場規模および予測は？

2.血漿療法市場で最も高い投資ポテンシャルを持つ製品、セグメント、用途、分野は？

3.血漿療法市場における競争戦略の窓とは？

4.血漿療法市場の最新技術動向と規制の枠組みは？

5.血漿療法市場における主要ベンダーの市場シェアは？

6.血漿療法市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 世界中で感染症や慢性疾患が蔓延
      • 病気の早期診断と治療への傾向
      • 血漿療法の有効性を検証する臨床試験の数が増加
    • 抑制要因
      • 血漿療法の処理に高額な費用がかかる
    • 機会
      • 多血小板の進歩血漿療法
      • 皮膚科における血漿療法の新たな使用法
    • 課題
      • 血漿療法に関連する悪影響
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 血漿療法市場：タイプ別

  • 白血球豊富なPRP
  • 白血球に富むフィブリン（L-PRF）
  • 純粋な多血小板フィブリン（PRF）
  • 純粋なPRP

第7章 血漿療法市場：用途別

  • 歯科
  • 皮膚科
  • 神経損傷
  • 整形外科

第8章 南北アメリカの血漿療法市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第9章 アジア太平洋地域の血漿療法市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第10章 欧州・中東・アフリカの血漿療法市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第11章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ主要企業別の分析

第12章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • Abeona Therapeutics Inc.
    • ADMA Biologics, Inc.
    • Arthrex, Inc.
    • Bio Products Laboratory Ltd.
    • Biotest AG
    • China Biologic Products, Inc.
    • CSL Limited
    • Emergent BioSolutions Inc.
    • Exactech Inc.
    • GC Pharma
    • Global Stem Cells Group, Inc.
    • Green Cross Corporation
    • Grifols, S.A.
    • Hualan Biological Engineering Inc.
    • Interstate Blood Bank, Inc.
    • Japan Blood Products Organization
    • Johnson & Johnson Services, Inc.
    • Kedrion S.p.A.
    • LFB S.A.
    • Octapharma AG
    • Regen Lab SA
    • Shanghai RAAS Blood Products Co., Ltd.
    • Stryker Corporation
    • Takeda Pharmaceutical Company Limited
    • Terumo Corporation
    • Zimmer Biomet Holdings, Inc
  • 主要な製品ポートフォリオ

第13章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. PLASMA THERAPY MARKET RESEARCH PROCESS
  • FIGURE 2. PLASMA THERAPY MARKET SIZE, 2022 VS 2030
  • FIGURE 3. PLASMA THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. PLASMA THERAPY MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 5. PLASMA THERAPY MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 6. PLASMA THERAPY MARKET DYNAMICS
  • FIGURE 7. PLASMA THERAPY MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
  • FIGURE 8. PLASMA THERAPY MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 9. PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 10. PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. AMERICAS PLASMA THERAPY MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 12. AMERICAS PLASMA THERAPY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES PLASMA THERAPY MARKET SIZE, BY STATE, 2022 VS 2030 (%)
  • FIGURE 14. UNITED STATES PLASMA THERAPY MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. ASIA-PACIFIC PLASMA THERAPY MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 16. ASIA-PACIFIC PLASMA THERAPY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA PLASMA THERAPY MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PLASMA THERAPY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 19. PLASMA THERAPY MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 20. PLASMA THERAPY MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. PLASMA THERAPY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. PLASMA THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PLASMA THERAPY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. PLASMA THERAPY MARKET SIZE, BY LEUCOCYTE-RICH PRP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. PLASMA THERAPY MARKET SIZE, BY LEUKOCYTE-RICH FIBRIN (L-PRF), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. PLASMA THERAPY MARKET SIZE, BY PURE PLATELET-RICH FIBRIN (PRF), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. PLASMA THERAPY MARKET SIZE, BY PURE PRP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 11. PLASMA THERAPY MARKET SIZE, BY DENTAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. PLASMA THERAPY MARKET SIZE, BY DERMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. PLASMA THERAPY MARKET SIZE, BY NERVE INJURY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. PLASMA THERAPY MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS PLASMA THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES PLASMA THERAPY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC PLASMA THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA PLASMA THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM PLASMA THERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. PLASMA THERAPY MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 102. PLASMA THERAPY MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 103. PLASMA THERAPY MARKET LICENSE & PRICING
目次
Product Code: MRR-DD0700E81EB3

The Plasma Therapy Market is projected to reach USD 781.95 million by 2030 from USD 328.91 million in 2022, at a CAGR of 11.43% during the forecast period.

Global Plasma Therapy Market

KEY MARKET STATISTICS
Base Year Value [2022] USD 328.91 million
Estimated Year Value [2023] USD 359.73 million
Forecast Year Value [2030] USD 781.95 million
CAGR (%) 11.43%
Plasma Therapy Market - IMG1

Market Segmentation & Coverage:

This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Plasma Therapy Market.

Based on Type, market is studied across Leucocyte-rich PRP, Leukocyte-rich Fibrin (L-PRF), Pure Platelet-rich Fibrin (PRF), and Pure PRP. The Pure PRP is projected to witness significant market share during forecast period.

Based on Application, market is studied across Dental, Dermatology, Nerve Injury, and Orthopedics. The Orthopedics is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Asia-Pacific is projected to witness significant market share during forecast period.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is an indispensable tool for assessing the Plasma Therapy Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.

Market Share Analysis:

The Market Share Analysis offers invaluable insights into the vendor landscape Plasma Therapy Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.

Key Company Profiles:

The report delves into recent significant developments in the Plasma Therapy Market, highlighting leading vendors and their innovative profiles. These include Abeona Therapeutics Inc., ADMA Biologics, Inc., Arthrex, Inc., Bio Products Laboratory Ltd., Biotest AG, China Biologic Products, Inc., CSL Limited, Emergent BioSolutions Inc., Exactech Inc., GC Pharma, Global Stem Cells Group, Inc., Green Cross Corporation, Grifols, S.A., Hualan Biological Engineering Inc., Interstate Blood Bank, Inc., Japan Blood Products Organization, Johnson & Johnson Services, Inc., Kedrion S.p.A., LFB S.A., Octapharma AG, Regen Lab SA, Shanghai RAAS Blood Products Co., Ltd., Stryker Corporation, Takeda Pharmaceutical Company Limited, Terumo Corporation, and Zimmer Biomet Holdings, Inc.

The report offers valuable insights on the following aspects:

1. Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.

2. Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.

3. Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.

4. Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.

5. Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast for the Plasma Therapy Market?

2. Which products, segments, applications, and areas hold the highest investment potential in the Plasma Therapy Market?

3. What is the competitive strategic window for identifying opportunities in the Plasma Therapy Market?

4. What are the latest technology trends and regulatory frameworks in the Plasma Therapy Market?

5. What is the market share of the leading vendors in the Plasma Therapy Market?

6. Which modes and strategic moves are suitable for entering the Plasma Therapy Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Plasma Therapy Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of infectious and chronic diseases worldwide
      • 5.1.1.2. Inclination towards early diagnosis and treatment of diseases
      • 5.1.1.3. Increase in number of clinical trials to test efficacy of plasma therapy
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of plasma therapy treatment
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in platelet-rich plasma therapy
      • 5.1.3.2. Emerging use of plasma therapy in dermatology
    • 5.1.4. Challenges
      • 5.1.4.1. Adverse effects associated with the plasma therapy
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Plasma Therapy Market, by Type

  • 6.1. Introduction
  • 6.2. Leucocyte-rich PRP
  • 6.3. Leukocyte-rich Fibrin (L-PRF)
  • 6.4. Pure Platelet-rich Fibrin (PRF)
  • 6.5. Pure PRP

7. Plasma Therapy Market, by Application

  • 7.1. Introduction
  • 7.2. Dental
  • 7.3. Dermatology
  • 7.4. Nerve Injury
  • 7.5. Orthopedics

8. Americas Plasma Therapy Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Plasma Therapy Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Plasma Therapy Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio

  • 12.1. Key Company Profiles
    • 12.1.1. Abeona Therapeutics Inc.
    • 12.1.2. ADMA Biologics, Inc.
    • 12.1.3. Arthrex, Inc.
    • 12.1.4. Bio Products Laboratory Ltd.
    • 12.1.5. Biotest AG
    • 12.1.6. China Biologic Products, Inc.
    • 12.1.7. CSL Limited
    • 12.1.8. Emergent BioSolutions Inc.
    • 12.1.9. Exactech Inc.
    • 12.1.10. GC Pharma
    • 12.1.11. Global Stem Cells Group, Inc.
    • 12.1.12. Green Cross Corporation
    • 12.1.13. Grifols, S.A.
    • 12.1.14. Hualan Biological Engineering Inc.
    • 12.1.15. Interstate Blood Bank, Inc.
    • 12.1.16. Japan Blood Products Organization
    • 12.1.17. Johnson & Johnson Services, Inc.
    • 12.1.18. Kedrion S.p.A.
    • 12.1.19. LFB S.A.
    • 12.1.20. Octapharma AG
    • 12.1.21. Regen Lab SA
    • 12.1.22. Shanghai RAAS Blood Products Co., Ltd.
    • 12.1.23. Stryker Corporation
    • 12.1.24. Takeda Pharmaceutical Company Limited
    • 12.1.25. Terumo Corporation
    • 12.1.26. Zimmer Biomet Holdings, Inc
  • 12.2. Key Product Portfolio

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing